Navigation Links
ePharmaSolutions To Acquire Global Patient Recruitment Firm Polaris BioPharma

CONSHOHOCKEN, Pa., June 20, 2012 /PRNewswire/ -- ePharmaSolutions announces the acquisition of Polaris BioPharma Consulting, a leading global patient recruitment and retention firm headquartered in Slough, UK.

ePharmaSolutions, a leading clinical services and technology solutions provider has acquired Polaris BioPharma Consulting to meet client demand for more "in-country" site feasibility and patient recruitment support on global clinical studies. This acquisition increases ePharmaSolutions' global bandwidth while expanding its core workforce with a team of experienced patient recruitment specialists in every major continent who can implement global projects at the local level.

"We have worked closely with Polaris over the last ten years on some very complex projects, and they have always delivered," stated Lance Converse, ePharmaSolutions' Founder and CEO.   "They have a wealth of knowledge of the regulatory, clinical and cultural landscape, from a local perspective, and have connections with varied regional referral sources to expedite study enrollment. This addition is integral to the company's continued growth."

Polaris Biopharma was founded in 1999 as a boutique patient recruitment and retention firm supporting global pharmaceutical companies.  Over the last 13 years, Polaris has grown to 20 local recruitment specialists in every continent providing in-country support on global recruitment campaigns.

"We are proud to be a part of ePharmaSolutions and committed to our collective mission to improve and accelerate clinical trials through empirical expertise in patient recruitment, compliance and retention," stated Sanjiv Kanwar, Polaris Biopharma's Managing Director.   "We can now fully leverage the data-driven technology assets ePharmaSolutions has developed with Polaris' global experience and regionally based recruitment specialists to provide Sponsors with high-impact, results-driven site feasibility and patient recruitment campaigns."

ePharmaSolutions and Polaris will be attending the Annual DIA Meeting in Philadelphia June 25th – 28th 2012 at booth 1427.

About ePharmaSolutions
ePharmaSolutions is a leading provider of technology-based clinical services that helps improve the way sites are selected, trained, activated and managed to exceed enrollment goals.  ePharmaSolutions won the 2009 Bio-IT World Award for best clinical trial technology and has activated and trained more than 260,000 clinical researchers in 120 countries for the top 20 pharmaceutical companies in the world.  ePharmaSolutions is headquartered in Philadelphia with offices in Slough, UK. For more information, visit or email

About Polaris Biopharma Consulting
Polaris Biopharma Consulting is a boutique patient recruitment and retention firm with over 20 regionally based recruitment specialists spanning each continent.   Polaris has helped large and mid-sized pharmaceutical companies and CROs develop and deploy hundreds of global feasibility, trial optimisation and patient recruitment programs in every major therapeutic area.  Polaris is headquartered in Slough, UK.   For more information visit or email

SOURCE ePharmaSolutions
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Chandler Chicco Companies Acquires Haas & Health Partner Public Relations and SanCom Creative Communication Solutions, Creating Unrivalled Healthcare Communication Capability in Germany
2. S.E.D. Labs to be Acquired by Quest Diagnostics
3. Celtaxsys Acquires Clinical Stage Innate Immunity Drug for Inflammation
4. TrovaGene Acquires CLIA - Certified Laboratory
5. Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services
6. Elsevier Acquires QUOSA, Provider of Life Sciences Content Management and Workflow Productivity Solutions
7. LoneStar Heart Acquires Worldwide Exclusive Rights to New Class of Small Molecules That May Lead to New Treatments for Diabetes
8. inVentiv Health to Acquire SDI Promotional and Medical Audit Businesses From IMS Health
9. GeneThera, Inc. Acquires Applied Genetics, S.A.
10. Amgen to Acquire Micromet
11. Camelot Healthcare Training Institute Acquired by Medtech
Post Your Comments:
(Date:10/11/2017)... ... October 11, 2017 , ... ... it will be hosting a Webinar titled, “Pathology is going digital. Is your ... on digital pathology adoption best practices and how Proscia improves lab economics and ...
(Date:10/11/2017)... ROTTERDAM, the Netherlands and LAGUNA HILLS, ... that The Institute of Cancer Research, London ... will use MMprofilerâ„¢ with SKY92, SkylineDx,s prognostic tool to risk-stratify ... high-risk trial known as MUK nine . The University ... this trial, which is partly funded by Myeloma UK, and ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... implantation and pregnancy rates in frozen and fresh in vitro fertilization (IVF) ... and maternal age to IVF success. , After comparing the results from the ...
(Date:10/10/2017)... , ... October 10, 2017 , ... San Diego-based team ... its corporate rebranding initiative announced today. The bold new look is part of ... the company moves into a significant growth period. , It will also expand its ...
Breaking Biology Technology:
(Date:3/30/2017)... March 30, 2017  On April 6-7, 2017, ... Genome hackathon at Microsoft,s headquarters in ... will focus on developing health and wellness apps that ... Hack the Genome is the first hackathon for ... world,s largest companies in the genomics, tech and health ...
(Date:3/28/2017)... , March 28, 2017 ... Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video ... and Region - Global Forecast to 2022", published by ... in 2016 and is projected to reach USD 75.64 ... 2017 and 2022. The base year considered for the ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by ... Global Forecast to 2022", published by MarketsandMarkets, the market is expected to be ... 2017 and 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):